DSM Venturing
DSM Venturing is the corporate venture arm of Royal DSM, investing in startups in sectors of animal and human health &a; nutrition and biomed.
Business Model:
Revenue: $9.6B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed DSM Venturing Information
Geographic Data
Address: Het Overloon 1
City: Heerlen
State: limburg
Zip: 6411
Country: NL
Financial Info
Stage:
Raised Last:
$0
Raised Total:$4B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Founded in 2001, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health &a; nutrition) and biomedical.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2007 | Ganeden Biotech | Venture Round | 0 |
| 3/2021 | Meatable | Series A | 47M |
| 2/2023 | Paleo | Series A | 0 |
| 11/2017 | Leading Edge Equipment Technologies | Convertible Note | 2.5M |
| 5/2020 | Phynova Group | Venture Round | 10.8M |
| 2/2009 | Viocare | Venture Round | - |
| 9/2018 | Novum Medical | Series C | 4.5M |
| 7/2015 | Natreon | Venture Round | 2.5M |
| 10/2010 | CellMade | Funding Round | 2.3M |
| 10/2014 | EyePromise | Venture Round | 3M |
| 11/2018 | Raycatch | Series B | - |
| 8/2009 | Novomer | Series B | 14M |
| 5/2005 | ORYXE Energy International | Venture Round | - |
| 6/2016 | NOMADD | Series A | 2.5M |
| 8/2018 | Chinova Bioworks | Seed Round | 0 |
| 2/2017 | QD Solar Inc. | Series A | 0 |
| 9/2004 | Sciona | Series B | 4.1M |
| 9/2016 | Essential Medical | Series B | 14.9M |
| 8/2016 | Arecor | Venture Round | 12M |
| 3/2013 | Arecor | Venture Round | - |
| 2/2019 | Adaptive3D | Series A | - |
| 7/2021 | Leading Edge Equipment Technologies | Convertible Note | 0 |
| 3/2017 | NutriLeads | Series A | - |
| 9/2022 | Rootine | Series A | 10M |
| 5/2012 | Regentis Biomaterials | Series C | 0 |
| 7/2015 | NovoPolymers | Venture Round | - |
| 11/2015 | NutriLeads | Seed Round | - |
| 12/2021 | ATRO Medical | Venture Round | 0 |
| 4/2006 | Sciona | Series C | 9.9M |
| 8/2020 | NutriLeads | Series B | 0 |
| 4/2020 | Panaceutics Nutrition | Series A | 0 |
| 3/2002 | Sciona | Series A | 4.2M |
| 8/2007 | Food Quality Sensor International | Series B | 5.6M |
| 9/2018 | Miach Orthopaedics | Series A | 22.5M |
| 1/2023 | Miach Orthopaedics | Series B | 0 |
| 7/2021 | Prenexus Health | Series B | 0 |
| 7/2021 | Additive Manufacturing Technologies | Series B | 0 |
| 8/2021 | Rootine | Seed Round | 0 |
| 1/2003 | Optiva | Series C | 0 |
| 10/2019 | Voxel8 | Series B | - |
| 3/2014 | Verdezyne | Venture Round | 0 |
| 8/2008 | Provexis | Post-IPO Equity | 2.8M |
| 3/2022 | OK Capsule | Seed Round | 0 |
| 10/2020 | Leading Edge Equipment Technologies | Series A | 7.6M |
| 3/2019 | Hyalex Orthopaedics | Series A | 17M |
| 5/2023 | VitaminLab | Series A | - |
| 5/2023 | Incredo | Series C | 0 |
| 5/2023 | Athian | Seed Round | - |
| 2/2023 | Meala Foodtech | Pre Seed Round | 0 |
| 1/2023 | OK Capsule | Series A | 0 |
| 11/2022 | Sun Genomics | Series B | - |
| 2/2021 | Frontier Nutrition | Series B | 6M |
| 7/2017 | ATRO Medical | Series A | - |
| 5/2022 | inne | Series A | 0 |
| 5/2011 | Verdezyne | Venture Round | - |
| 9/2019 | Chinova Bioworks | Seed Round | 0 |
| 10/2019 | Additive Manufacturing Technologies | Series A | 6.4M |
| 9/2022 | Momentous | Series A | 0 |
| 2/2004 | Morphotek | Series C | 26M |
| 3/2014 | Isobionics | Venture Round | - |
| 7/2022 | Phytolon | Series A | 14.5M |
| 6/2021 | Brains Bioceutical | Series A | 31.9M |
| 9/2007 | Upfront Chromatography | Venture Round | 9.2M |
| 6/2022 | Chinova Bioworks | Series A | 0 |
| 11/2006 | IntegraGen | Venture Round | 2.5M |
| 9/2016 | Blue Prairie | Series A | 0 |
| 8/2019 | ZeaVision | Venture Round | - |
| 9/2022 | Octarine Bio | Seed Round | 0 |
| 8/2012 | Segetis | Series C | 0 |
| 1/2010 | Segetis | Series B | 17.2M |
| 3/2021 | Deep Branch Biotechnology | Series A | 0 |
| 11/2019 | Inkbit | Venture Round | 0 |
| 4/2019 | Panaceutics Nutrition | Venture Round | - |
| 7/2012 | Xolve | Funding Round | 2.1M |
| 10/2013 | ChromaDex | Post-IPO Equity | 3M |
| 1/2015 | Interface Biologics, Inc. | Series B | - |
| 2/2017 | WattGlass | Series A | - |
| 4/2018 | Tespo | Series A | 3.5M |
| 2/2007 | Harland Medical Systems | Venture Round | - |
| 3/2021 | Novum Medical | Venture Round | - |
| 11/2006 | Micromuscle | Venture Round | - |
| 4/2018 | Chromatic 3D Materials | Series A | - |
| 5/2023 | DouxMatok | Series C | 0 |
| 5/2023 | VitaminLab | Series A | - |
| 5/2023 | Athian | Seed Round | - |
| 2/2023 | Paleo | Series A | 0 |
| 2/2023 | Meala Foodtech | Pre Seed Round | 0 |
| 1/2023 | Miach Orthopaedics | Series B | 0 |
| 1/2023 | OK Capsule | Series A | 0 |
| 11/2022 | Sun Genomics | Series B | - |
| 9/2022 | Octarine Bio | Seed Round | 0 |
| 9/2022 | Momentous | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
